| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
5e-07 |
| mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-07 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
7e-06 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
9e-06 |
| mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
4e-05 |
| mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
5e-05 |
| mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
7e-05 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
8e-05 |